Part 12: cardiac ar- rest in special situations: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2010;122:S829 61. 521. Ersb ll AS, Hedegaard M, S ndergaard L, et al. Treatment with oral beta-blockers during pregnancy complicated by maternal heart disease increases the risk of fetal growth restriction. BJOG. 2014;121:618 26. 522. Allen NM, Page RL. Procainamide administration during pregnancy. Clin Pharm. 1993;12:58 60. 523. Bartalena L, Bogazzi F, Braverman LE, et al. Effects of amiodarone ad- ministration during pregnancy on neonatal thyroid function and subse- quent neurodevelopment. J Endocrinol Invest. 2001;24:116 30. 524. Meidahl Petersen K, Jimenez-Solem E, Andersen JT, et al. -Blocker treatment during pregnancy and adverse pregnancy outcomes: a nation- wide population-based cohort study. BMJ Open. 2012;2. 525. Lydakis C, Lip GY, Beevers M, et al. Atenolol and fetal growth in preg- nancies complicated by hypertension. Am J Hypertens. 1999;12:541 7. 526. Szumowski L, Szufladowicz E, Orczykowski M, et al. Ablation of se- vere drug-resistant tachyarrhythmia during pregnancy. J Cardiovasc Electrophysiol. 2010;21:877 82. 527. Damilakis J, Theocharopoulos N, Perisinakis K, et al. Conceptus radia- tion dose and risk from cardiac catheter ablation procedures. Circulation. 2001;104:893 7. 528. McCollough CH, Schueler BA, Atwell TD, et al. Radiation expo- sure and pregnancy: when should we be concerned? Radiographics. 2007;27:909 17. 529. Colletti PM, Lee KH, Elkayam U. Cardiovascular imaging of the preg- nant patient. AJR Am J Roentgenol. 2013;200:515 21. 530. Chen SA, Lee SH, Wu TJ, et al. Initial onset of accessory pathway-medi- ated and atrioventricular node reentrant tachycardia after age 65: clinical features, electrophysiologic characteristics, and possible facilitating fac- tors. J Am Geriatr Soc. 1995;43:1370 7. 531. Chen SA, Chiang CE, Tai CT, et al. 